Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
A phase II clinical trial (NCT03163667) indicated that CB-839 and mTOR inhibitor (everolimus) showed good tolerability and improved progression-free survival in patients when treating advanced clear cell renal cell carcinoma (ccRCC) (Lee et al., 2022)
Cons: contains soy, only 30 softgels per bottle (15-30 day supply), premium price, gelatin capsule (not vegan)
Analgesic activity in chronic pain models appears in the older literature, as do neuroprotective effects, effects on oxidative stress and on inflammation, and general neuromodulatory or neuromodulation framing
Nutrition: Keep protein intake adequate and overall diet balanced to support metabolism and lean mass
US$ 25.16
US$ 23.52
US$ 29.14
